Strumento inattivo

Altre lingue Radius Health, Inc.

Azioni

RDUS

US7504692077

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

EffRx Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with Radius Health, Inc for Binosto for the United States	19/09/23
Radius Health, Inc. Announces the Appointment of Al Medwar as Senior Vice President and Corporate Development	27/07/23
Radius Health, Inc. Appoints Erika Tooman as Senior Vice President/ General Counsel	06/04/23
Theramex Enters into an Exclusive Licensing Agreement with Radius Health Inc, to Commercialise ELADYNOS in the European Economic Area, United Kingdom, Australia and Brazil	20/03/23
Radius Health, Inc. announced that it has received funding from Webster Equity Partners, LLC	31/12/22
Radius Health's Tymlos® (Abaloparatide) Receives U.S. FDA Approval as A Treatment to Increase Bone Density in Men with Osteoporosis At High Risk for Fracture	20/12/22
Ambrx Biopharma Names Kate Hermans Interim CEO	16/08/22
RADIUS HEALTH, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or (form 8-K)	15/08/22
Radius Health, Inc. Announces Board Changes	15/08/22
Radius Health, Inc. Enters into Credit Agreement	15/08/22
Gurnet Point Capital and Patient Square Capital Complete Their Acquisition of Radius Health, Inc.	15/08/22
Gurnet Point Capital and Patient Square Capital Complete Their Acquisition of Radius Health, Inc.	15/08/22
Radius Health, Inc.(NasdaqGM:RDUS) dropped from NASDAQ Composite Index	15/08/22
Radius Health, Inc.(NasdaqGM:RDUS) dropped from S&P TMI Index	15/08/22
Radius Health, Inc.(NasdaqGM:RDUS) dropped from S&P Global BMI Index	15/08/22
Radius Health, Inc.(NasdaqGM:RDUS) dropped from S&P Biotechnology Select Industry Index	15/08/22
Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer	11/08/22
Radius Health: Q2 Earnings Snapshot	10/08/22
Radius Health, Inc.(NasdaqGM:RDUS) dropped from NASDAQ Biotechnology Index	10/08/22
Patient Square Capital, LP and Gurnet Point Capital Limited completed the acquisition of Radius Health, Inc. from Repertoire Partners LP, Velan Capital Investment Management LP and others.	10/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Radius Health, Inc.

Azioni

RDUS

US7504692077

Altre lingue

Filtri